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PD-1/PD-L1 Pathway Modulates 
Macrophage Susceptibility to 
Mycobacterium tuberculosis Specific 
CD8+ T cell Induced Death
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César Ariel Trifone1, José Luis Marín Franco2, Melanie Genoula2, Eduardo José Moraña3, 
Luciana Balboa2 & Maria Florencia Quiroga  1
CD8+T cells contribute to tuberculosis (TB) infection control by inducing death of infected 
macrophages. Mycobacterium tuberculosis (Mtb) infection is associated with increased PD-1/PD-L1 
expression and alternative activation of macrophages. We aimed to study the role of PD-1 pathway 
and macrophage polarization on Mtb-specific CD8+T cell-induced macrophage death. We observed 
that both PD-L1 on CD14+ cells and PD-1 on CD8+T cells were highly expressed at the site of infection 
in pleurisy TB patients’ effusion samples (PEMC). Moreover, a significant increase in CD8+T cells’ 
Mtb-specific degranulation from TB-PEMC vs. TB-PBMC was observed, which correlated with PD-1 
and PDL-1 expression. In an in vitro model, M1 macrophages were more susceptible to Mtb-specific 
CD8+T cells’ cytotoxicity compared to M2a macrophages and involved the transfer of cytolytic effector 
molecules from CD8+T lymphocytes to target cells. Additionally, PD-L1 blocking significantly increased 
the in vitro Ag-specific CD8+T cell cytotoxicity against IFN-γ-activated macrophages but had no effect 
over cytotoxicity on IL-4 or IL-10-activated macrophages. Interestingly, PD-L1 blocking enhanced Mtb-
specific CD8+ T cell killing of CD14+ cells from human tuberculous pleural effusion samples. Our data 
indicate that PD-1/PD-L1 pathway modulates antigen-specific cytotoxicity against M1 targets in-vitro 
and encourage the exploration of checkpoint blockade as new adjuvant for TB therapies.
Mycobacterium tuberculosis (M. tuberculosis, Mtb) has the ability to manipulate cell death pathways in infected 
macrophages, which constitutes a virulence mechanism for this pathogen1. While virulent strains of M. tubercu-
losis induce necrosis of infected macrophages and actively inhibit the induction of macrophage apoptosis, atten-
uated M. tuberculosis strains generally do not. Additionally, cumulative evidence shows that apoptosis results in 
lower viability of M. tuberculosis induced pharmacologically either by the pathogen itself or by cytotoxic lympho-
cytes2. Also, apoptotic infected macrophages release less viable bacilli than necrotic macrophages3, which leads 
to the hypothesis that infected cell necrosis may be exploited by M. tuberculosis to propagate across the infected 
organism. On the other hand, while intracellular milieu of infected macrophages is completely modified by 
M. tuberculosis in its own favor leading to the establishment of an innocuous microenvironment to the bacteria, 
phagocytosis of apoptotic bodies containing viable bacteria by uninfected macrophages can lead to the definitive 
death of the bacilli in a process called efferocytosis4. This mechanism not only contributes to bacterial clearance 
but also it is fundamental to M. tuberculosis antigens presentation by dendritic cells to naïve CD8+ T cells, con-
tributing to the start and preservation of CD8+ T cell responses against the pathogen4.
Evidence pointing to an essential role of CD8+ T cells during M. tuberculosis infection in humans is scarce. 
In this sense, the relevance of cytotoxic anti-tubercular immune responses have been highlighted in humans, 
since it has been reported that anti-TNF-α blocking antibodies administration leads to the elimination of a 
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terminally-differentiated CD8+ T cell population in rheumatoid arthritis patients with latent tuberculosis infec-
tion. This is thought to be partly responsible for their increased predisposition to TB reactivation5. Also, recent 
evidence suggests that CD8+ T cells contribute to the optimal control of M. tuberculosis infection through several 
effector mechanisms, including the induction of infected-macrophage apoptosis (i.e., cytotoxicity)6,7. Finally, we 
have already described a deficient CD8+T cell differentiation in the context of HIV-TB co-infection, which has 
an impact on cell functionality8.
M. tuberculosis control relies fundamentally on bactericidal mechanisms induced by the activation of infected 
macrophages. Furthermore, macrophage activation is heterogeneous, and it is divided into three different profiles: 
M1 macrophages, which are differentiated in response to type 1 cytokines (like IFN-γ) and microbial products; 
M2a macrophages are induced by type 2 cytokines (like IL-4 or IL-13) and M2b/c macrophages are induced by 
regulatory signals (like IL-10 or immune complexes)9. Previously, it was demonstrated that M1 polarization of 
macrophages is critical for M. tuberculosis control, with M1 macrophages promoting granuloma formation and 
macrophage bactericidal activity, and M2-polarized macrophages inhibiting these effects10. In this regard, it has 
been shown that the Early Secreted Antigenic Target 6 kDa or ESAT-6, a pathogenicity mycobacterial factor, has 
the potential to switch human macrophages from an M1 to an M2 phenotype11. Also in mice, the avirulent strain 
H37Ra induces M1-related molecules of M. tuberculosis infected macrophages, whereas its virulent counterpart 
H37Rv induces an M2-phenotype, highlighting the relevance of mycobacterial virulence factors on macrophage 
function12. Conversely, IL-4 activation of macrophages deprives them of the control mechanisms to limit myco-
bacterial growth, allowing its persistence within infected macrophages13.
Although the role of macrophage activation in M. tuberculosis control is well established14,15, the consequences 
of macrophage polarization on their susceptibility to CD8+ T cell-killing machinery have been poorly explored. 
Furthermore, the relevance of inhibitory checkpoints in this cellular interaction (i.e., the interaction between 
CD8+ T lymphocytes and polarized macrophages) is a completely unexplored issue, even outside the field of 
human infections.
The role of the PD-1/PD-L pathway, which is fundamental in T cell biology16, is controversial in the context 
of M. tuberculosis infection. Considering other diseases, it was shown that the PD-1/PDL pathway is an impor-
tant checkpoint in cancer immunotherapy, since the inhibition of this pathway enhances tumor-specific CD8+ 
T-cell responses17–19. Moreover, a novel therapeutic strategy aimed at blocking the PD-1 expression on human 
antigen-specific cytotoxic T-lymphocytes has been described based on CRISPR-the Cas9 genome editing20. In 
human tuberculosis, while some authors demonstrated that the induction of PD-1 expression during infection 
is detrimental as it inhibits protective adaptive immune responses21,22, others have shown that its induction is 
necessary to inhibit the exacerbated immune response that leads to tissue damage during active infection23,24. Yet, 
the role of this pathway on the regulation of the CD8+ T cell function during M. tuberculosis infection has not 
been studied thoroughly25.
In this context, the data presented here shows that while M1 macrophages are more susceptible to 
antigen-specific CD8+ T cell killing, the greater expression of PDL-1 on M1 target cells counteracts the activation 
of CD8+ T cells, inhibiting macrophage killing by cytotoxic effectors. We also demonstrate that PD-1 and PDL-1 
are highly expressed at the site of infection during human tuberculosis and that these molecules are involved in 
Mtb-specific cytotoxic killing of CD14+ targets cells from human pleura effusion (PE) samples. Altogether, our 
results encourage the exploration of CD8-targeted anti-PD-1 blockade as a new adjuvant therapy for tuberculosis 
treatment.
Methods
TB-pleurisy patients. Pleural effusion (PE) and paired peripheral blood (PB) samples were collected from 
HIV-negative TB pleurisy patients following standard procedures for diagnosis purposes at the Hospital de 
Infecciosas “Dr. Francisco Javier Muñiz”, Buenos Aires, Argentina. The research was carried out in accordance 
with the World Medical Association Declaration of Helsinki (2013), and approved by the Ethics Committees of 
the Hospital “Francisco J. Muñiz” and the Academia Nacional de Medicina de Buenos Aires (protocol number: 
NIN-2612-17). Written informed consents were obtained from all participants before sample collection. The 
diagnosis of tuberculous pleurisy was based on a positive Ziehl–Nielsen stain or Lowestein–Jensen culture from 
PE and/or histopathology of pleural biopsy, and was further confirmed by an M. tuberculosis-induced IFN-γ 
response and an ADA-positive test26. None of the patients had multidrug-resistant TB or received anti-tuber-
culosis treatment before sample collection. The male/female group distribution was 18/4 and the median age 
was 39 years, interquartile range (IQR) 18–75 years. In addition to TB pleurisy patients, 13 individuals latently 
infected with M. tuberculosis were enrolled (male/female distribution 3/2, median age 42 years, IQR 25–85 years). 
The entire group of individuals were BCG (Bacillus Calmette-Guerin)-vaccinated at birth. Mononuclear cell 
were isolated from pleural effusion (PEMC) and blood samples (PBMC) by Fycoll-Paque PLUS® gradient (GE 
Healthcare Life Sciences). Then, PBMC or PEMC were stained by PD-L1 PE, CD8 APC or PerCP, CD3 FITC, 
CD14 APC, PD-1 PE (BD Biosciences), CD27 APC, CD45RA PE-Cy7 (Biolegend) and NearER Live Dead rea-
gent (Invitrogen) and analyzed in a FACSCanto flow cytometer (BD Bioscences). In another set of experiments, 
cytotoxic degranulation of CD8+ T cells was assessed by CD107a/b expression (20 μL/mL; BD Biosciences) after 
culture in the presence of M. tuberculosis, as described by our group and elsewhere8,22,27. Data was analyzed using 
the FlowJo® v10.0.8 software (FlowJo, LLC).
In vitro differentiation and polarization of macrophages. Monocytes were purified from PBMC 
obtained from 30 blood buffy-coats (provided by the Hemotherapy Division, Sanatorio “Dr. Julio Mendez”, 
Buenos Aires, Argentina), by Fycoll-Paque PLUS® gradient followed by Percoll® gradient (GE Healthcare Life 
Sciences). All healthy donors were between 18–65 year old; completed and passed a survey on blood dona-
tion; and were screened for serological markers of HIV, HCV, HBV, HTLV-I/II, Syphilis, Chagas disease, and 
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Figure 1. Expression of PD-1 and PD-L1 in cells from pleurisy TB patients’ pleural effusions. (A) Upper panel. 
MFI of PD-L1 (left) and % of PD-L1+ cells (right) in CD14+ cells from peripheral blood or pleural effusions 
from pleurisy TB patients (TB), peripheral blood from latent TB infected individuals (LTB) or healthy donors 
(HD). Each symbol represents an individual subject. Horizontal lines represent median values and whiskers 
represent interquartile range. p < 0.05; **p < 0.01; ***p < 0.001 by ANOVA followed by Dunn’s posttest. 
Lower panel. Flow cytometry histograms depicting PDL-1 expression of CD14+ cells from representative 
individuals among each group. (B) PD-1 expression on PEMC or PBMC CD8+ T cells from TB patients. 
Horizontal lines connect data from each individual (right panel). A representative cytogram from peripheral 
blood (left panel) or pleural effusion mononuclear cells (center) is shown. **p < 0.01, Wilcoxon Signed Rank 
Test. (C) Representative cytograms depicting CD27 and CD45RA expression on CD3+/CD8+/PD-1+ cells 
from peripheral blood (left) or pleural effusion (right) TB samples. Bottom: pie charts summarize the data 
and each slice corresponds to the mean proportion of CD3+/CD8+/PD-1+ cells for each phenotype. Bar graph 
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Brucellosis, before being enrolled. Cell purity was evaluated by flow cytometry through forward vs. side scatter 
plots. Samples with purity lower than 60% of monocytes were discarded. Monocytes were then plated at 1 × 106 
cells/ml in 24 well culture plates using FBS-free RPMI 1640 (Sigma-Aldrich). Adhesion was achieved by incubat-
ing cells for 1 h at 37 °C. After washing cells with PBS, adherent cells were cultured in RPMI 1640 (Sigma-Aldrich) 
supplemented with 10% FBS (Gibco, Thermo Fisher Scientific), L-glutamine (2 mM), penicillin (100 U/ml), 
streptomycin (100 μg/ml, Gibco, Thermo Fisher Scientific) and GM-CSF (30 ng/ml, Miltenyi Biotec). After 5 
days, in order to induce macrophage polarization, macrophages were detached and re-plated in the presence of 
the following cytokine cocktails: GM-CSF (30 ng/ml) plus IFN-γ (M1, 500 UI/ml, BEI resources, NR-3086), IL-4 
(M2a, 10 ng/ml, Miltenyi Biotec) or IL-10 (M2c, 10 ng/ml, Miltenyi Biotec) for 2 additional days. Non-polarized 
macrophages (cultured in the presence of GM-CSF) were used as control in each experiment. Also, macrophages 
from different donors were polarized in each independent experiment.
The day of the experiment, macrophage phenotype was evaluated by assessing several markers by flow cytom-
etry, as reported previously28. Data were analyzed with FlowJo Software (Version 10.4, Tree Star) after gating on 
the myeloid population in the FSC/SSC window and excluding cell aggregates (doblets) by FSC-A/FSC-H. To 
normalize the results from independent experiments, values were depicted as the ratio of the geometric mean 
fluorescence intensity (MFI) of the marker of interest over the MFI of the corresponding isotype control.
In vitro cytotoxicity assays. Preparation of effector CD8+ T cells. PBMC from buffy coats were isolated 
by Fycoll-Paque PLUS® gradient and cultured at 15 × 106 cells per well in 5 ml of complete RPMI (RPMI 1640 - 
Sigma-Aldrich- supplemented with 10% FBS -Gibco, Thermo Fisher Scientific-, L-glutamine −2 mM-, penicillin − 
100 U/ml-, streptomycin −100 μg/ml, Gibco, Thermo Fisher Scientific-) in 6 multi-well plates and cultured in 
the presence of M. tuberculosis (10 μg/ml, equivalent to a bacillus/cell ratio = 0.25 of Mycobacterium tuberculosis, 
Strain H37Rv, Gamma Irradiated Whole Cells, NR-14819 BEI Resources, NIAID, NIH) or Cytomegalovirus, 
Epstein Barr and Influenza (CEF) Control Peptide Pool (1 ng/ml, NIH AIDS Reagent Program, Division of AIDS, 
NIAID, NIH) plus IL-2 (100 ng/ml) for 7 days at 37 °C in a humidified atmosphere rich in CO2. Afterwards, CD8+ 
T cells were washed, isolated performing a negative selection protocol, as indicated by the manufacturer (CD8+ T 
cell isolation kit, Miltenyi Biotec), re-suspended in fresh culture media and proceeded to perform the cytotoxicity 
assays.
Preparation of target cells and cytotoxicity assay. The day of the experiment, polarized macrophages were loaded 
with pre-titrated M. tuberculosis (10 μg/ml, equivalent to a bacillus/cell ratio = 0.25) for 2 h, CEF (5 ng/ml) for 1 h 
or anti-CD3 antibodies (5 μg/ml) for 10′, washed and co-cultured with autologous isolated CD8+ T cells. CD8+ 
T cells were previously stimulated with M. tuberculosis or CEF as described above and boosted with phorbol-
12-miristate-13-acetate (PMA) and Ionomycin (5 ng/ml and 500 ng/ml respectively, Sigma-Aldrich) for 10’ and 
washed extensively. Unless indicated, experiments were performed at a final CD8+ T cell: macrophage ratio of 2:1 
in 200 μl of complete RPMI for 18 h.
After co-culture, adherent and non-adherent cells were collected by detachment with a trypsin solu-
tion (TrypLE™ Express, Thermo Fisher Scientific), washed and immediately incubated for 10′ with 
7-amino-actinomycin D solution (7-AAD, Thermo Fisher Scientific) as indicated by the manufacturer. Then, 
cells were analyzed by flow cytometry in a FACSCanto (BD Biosciences) flow cytometer. Data was analyzed with 
FlowJo® v10.0.8 software (FlowJo, LLC). In a separate set of experiments, pleural effusion target cells were iso-
lated by positive selection (CD14 Microbeads, Miltenyi Biotec) and CD8+ cells were isolated by negative selection 
(CD8+ T Cell Isolation Kit, Miltenyi Biotec). Afterwards, cytotoxicity assay was performed as indicated above.
Statistical analysis. Statistical analyses were conducted using GraphPad Prism software version 5.01. 
Comparisons between two groups were evaluated by the Wilcoxon test for paired samples. Alternatively, compar-
isons among three or more groups were done using the Kruskal–Wallis analysis of variance, followed by post-hoc 
comparisons (Dunns), or using the ANOVA test followed by the Bonferroni test, when applicable. For paired 
samples, Friedman test was performed. Correlation analyses were determined using the Spearman’s rank test. 
Statistical analysis and display of multicomponent distributions were performed by partial permutation test using 
SPICE v5.1 (http://exon.niaid.nih.gov/spice/). For all statistical comparisons, a p value < 0.05 was considered 
significant.
represents possible phenotypes, which are shown on the x-axis whereas percentages of distinct T-cell subsets 
within CD3+/CD8+/PD-1+ cells are shown on the y-axis. Horizontal lines represent the median range and each 
point represents an individual subject; asterisks indicate a significant difference between groups; #p < 0.05. 
Comparisons of phenotype distribution were performed using the partial permutation test as described in ref.32 
and the Kruskal–Wallis test followed by Dunn’s multiple comparisons posttest. (D) Upper panel: CD107a/b 
expression in CD8+ T cells after Mtb-stimulation of PBMC or PEMC from TB patients. Horizontal lines 
connect data from each individual. **, p < 0.01, non-parametric student t Test for paired samples. Middle: 
Correlation analysis between PD-1 expression on CD8+ T cells and CD107a/b in CD8+ T cells from TB PEMC 
and PBMC. p = 0.0287, r2 = 0.5183. Lower panel: Correlation analysis between the %PD-L1 expression on 
CD14+ cells and CD107a/b in CD8+ T cells from TB PEMC and PBMC. p = 0.0477, r2 = 0.4056.
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Figure 2. Effect of macrophage polarization on in vitro CD8+ T cell-mediated cytotoxicity. (A) Graphical 
description of the cytotoxicity assay. Monocyte derived macrophages were differentiated from peripheral 
blood by culturing monocytes with GM-CSF (30 ng/ml) for 6–7 days alone or supplemented with IFN-γ (500 
U/ml), IL-4 (10 ng/ml) or IL-10 (10 ng/ml) for 2 additional days. Then, macrophages were cultured with M. 
tuberculosis (10 μg/ml) or CEF (1 ng/ml) as described in Methods. After that, macrophages were co-cultured for 
18 h with syngeneic CD8+ T cells previously expanded with Mtb or CEF + IL-2 as described in Methods. Finally, 
macrophage death was determined by 7-AAD incorporation by flow cytometry. (B) FSC-A vs. 7-AAD dot plots 
of representative co-cultures of CD8+ T cells and macrophages (2:1 ratio) loaded with Mtb. (C) Figure shows 
the percentage of 7-AAD+ macrophages from 13 independent experiments, each one including one donor 
assayed by duplicate. Horizontal lines connect data from media and Mtb-stimulated macrophages cultured 
under each polarizing condition. ***p < 0.001 by ANOVA followed by Bonferroni post-test. (D) Comparison 
of CD8-induced macrophage death between polarizing conditions. Media values were subtracted and negative 
values were set to 0. **p < 0.01 by ANOVA followed by Bonferroni posttest.
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Figure 3. Transfer of effector molecules from cytotoxic lymphocytes to macrophages. (A) Representative Dot 
plots depicting the gating strategy for analyzing the transfer of Granzyme B (Grz B) from syngeneic CD8+ T 
cell effectors to macrophages loaded with Mtb. Figure shows from left to right (upper panel): FSC-A vs. SSC-A 
indicating macrophages and lymphocytes; CD3 vs. CD8 within the gate of macrophages, indicating double 
positive (Macrophages [Mo]-CD8+ T Ly cells complexes) and double negative (Unassociated Mo) events; 
Granzyme B (Gzm B) histogram, depicting Gzm B in unassociated lymphocytes (gated in the FSC/SSC graph, 
marked as Unconj. CD8+ T cells) vs. macrophage-associated lymphocytes, marked as CD8+T-Mo). Lower left 
panel: Gzm B in unassociated GM-CSF-treated macrophages from the co-cultures in media (pink) and Mtb 
(light blue). Inset numbers indicate median fluorescence intensity according to color code. Middle: Gzm B 
in unassociated IFN-γ-polarized macrophages from co-cultures in media (pink) and Mtb (light blue). Inset 
numbers indicate median fluorescence intensity according to color code. One representative example of three 
independent experiments performed in duplicate is shown. Right: Figure shows the MFI of intracellular Gzm 
B in un-conjugated macrophages before and after Mtb stimulation from 3 independent experiments, each 
one including one donor assayed by duplicate. (B) Effect of Mtb-stimulation on cytotoxic Granulysin (Gly, 
www.nature.com/scientificreports/
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Results
Up-regulation of PD-1 pathway molecule expression on cells from TB pleurisy patients. The 
role of PD-1/PDLs as negative regulators of T-cell effector functions has been extensively studied21,24,29. Also, the 
study of cytotoxic T-cells in tuberculosis is an issue of increasing relevance, because CD8+ T cells not only pro-
duce IFN-γ, a macrophage-activating cytokine30, but also are able to kill infected macrophages5. In this context, 
we aimed to assess the expression of PD-1 pathway receptors on peripheral blood mononuclear cells (PBMC) and 
TB pleural effusion CD8+T cells and CD14+ cells. Thus, we observed that the expression of PD-L1 in CD14+ cells 
from pleural effusion mononuclear cells (PEMC) was highly increased compared to PBMC CD14+ cells from 
TB patients and also to peripheral CD14+ cells from individuals with latent TB or healthy donors, both in terms 
of the expression level on a per-cell basis or the percentage of positive cells (Fig. 1A). On the other hand, when 
analyzing the phenotype of CD8+ T cells, we observed that the PD-1 expression was significantly higher in CD8+ 
T cells from PEMC compared to paired peripheral CD8+ T cells from TB patients (Fig. 1B). T cells were pheno-
typically discriminated in terms of CD27/CD45RA expression by flow cytometry as naïve (TN), central memory 
(TCM), effector memory (TEM), and terminal effector (TTE) T lymphocytes, as described by us previously31. Thus, 
partial permutation test32 evinced that, in contrast to peripheral blood cells, CD8+ PD-1+ T cells from pleural 
effusion exhibited a distinct effector/memory population distribution (Fig. 1C, pies) with a predominant central 
memory phenotype (p = 0.05 comparing TCM between PD-1+ PBMC and PD-1+ PEMC, Fig. 1C, Bars), there-
fore suggesting an exhausted phenotype in the pleural compartment8,33. Moreover, the observation of a memory 
exhausted phenotype in the PD-1 compartment was corroborated by comparing PD-1+ and bulk CD8+ T cells, 
which revealed a significantly dissimilar effector/memory distribution between both populations in peripheral 
blood and also in the pleural compartment (p = 0.0053 and p = 0.0040, respectively by partial permutation test, 
Supplementary Fig. 1). In the PE context, these differences were due to diminished naïve and terminal effector 
cells and higher central memory T cells in PD-1+ cells (p = 0.006 comparing TN between PE-PD-1+ and PE-T 
CD8+; p = 0.006 comparing TCM in PE-PD-1+ and PE-T CD8+ and p = 0.045 comparing TTE in PE-PD-1+ and 
PE-T CD8+). In contrast, in peripheral blood those differences were due to lower naïve cells and higher pro-
portions of central memory and effector memory cells (p = 0.048 comparing TN between PB-PD-1+ and PB-T 
CD8+; p = 0.041 comparing TEM in PB-PD-1+ and PB-T CD8+ and p = 0.002 comparing TCM in PB-PD-1+ and 
PB-T CD8+, Supplementary Fig. 1A). Interestingly, in addition to a significant increase in cytotoxic Mtb-specific 
degranulation by CD8+ T cells from TB-PEMC vs. TB-PBMC (measured as CD107a/b+ CD8+ T cells after Mtb 
stimulation, Fig. 1D -upper panel-), a positive correlation was observed between PD-1 expression on CD8+ T 
cells or PDL-1 expression on CD14+ cells, and the cytotoxic capacity of CD8+ T cells (Fig. 1D, middle and lower 
panel, respectively). Finally, since both PD-1 and PDL-1 expression levels are regulated by IFN-γ34 we assessed 
this cytokine’s concentration and observed higher IFN-γ concentrations in pleural effusions compared to periph-
eral blood (Supplementary Fig. 1B). Overall, these results show an increase in both PD-1 and PD-L1 expressions, 
higher IFN-γ concentrations and increased CD8-mediated cytotoxicity at the site of infection during TB pleurisy.
Macrophage susceptibility to antigen-specific CD8+ T cell mediated cytotoxicity is related to 
macrophage-polarization state. It has been described that Mtb infection could modulate macrophage 
polarization from an M1 profile to an M2-like one11,12. However, the susceptibility of polarized macrophages to 
Ag-specific CD8+ T cell killing is an unexplored issue. In order to shed light over this question, we induced mac-
rophage polarization by culturing cells in the presence of IFN-γ, IL-4 or IL-10, and validated the cell phenotype 
by analyzing the expression of several surface markers by flow cytometry as reported previously28. Therefore, 
to assess the Ag-specific cytotoxicity, we adapted a method that allows the quantification of target cell death 
by 7-AAD incorporation and flow cytometry detection, as depicted in Fig. 2A35. To achieve that, macrophages 
were loaded with gamma-irradiated M. tuberculosis, or with a pool of antigens from Cytomegalovirus, Epstein 
Barr and Influenza (CEF) as a positive control for CD8+ T cell responses, since CEF encompass a set of anti-
gens which are known to induce Ag-recall responses in human donors36. Afterwards, loaded macrophages were 
co-cultured with autologous CD8+ T cells expanded previously in the presence of the same antigens. Finally, 
target cell death was determined by 7-AAD exclusion within the macrophage gate by flow cytometry (Fig. 2B–D 
and Supplementary Fig. 2).
Our results show that both M1-polarized and M0 (GM-CSF-treated) macrophages were susceptible to 
Mtb-specific CD8+ T cell mediated killing, whereas alternatively activated macrophages (IL-4 or IL10) were 
not (Fig. 2C). Since basal macrophage death was dissimilar between IFN-γ and IL-4 polarizing treatments 
(Supplementary Fig. 3), we subtracted media values to Ag-specific cytotoxicity values and compare between 
treatments. Thus, we observed that M1-polarized macrophages were more susceptible than alternatively (IL-4) 
activated macrophages to Mtb-specific CD8+ T cell mediated killing (Fig. 2B,D). This increased susceptibility 
was independent of the nature of the antigen, as both M. tuberculosis (Fig. 2B,D) and CEF (Supplementary Fig. 4) 
antigens induced increased proportions of 7-AAD+ macrophages following co-culture. On the contrary, IL-4 or 
IL-10 polarization did not significantly increase CD8+ T cells’ mediated cytotoxicity over macrophages loaded 
upper panel) and Perforin (Pfn, lower panel) transfer to macrophages. Histograms depict Gly and Pfn staining 
by flow cytometry in GM-CSF-treated macrophages loaded with Mtb antigens after 18 h co-culture with 
syngeneic CD8+ T cells in in media (pink) and Mtb (light blue). Inset numbers indicate median fluorescence 
intensity according to color code. (C) Gzm B staining in fixed 18 h Mø/CD8+ T cell co-cultures. Figure shows 
epifluorescence and DIC photographs of a macrophage (white arrow) and a CD8+ T cell (green arrow) in tight 
contact. One representative experiment of three independent experiments (one donor each) is shown.
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Figure 4. Study of the expression of HLA-ABC, HLA-DR, CD80, CD86, CD64 and PDL-1 on IFN-γ-, IL-4- 
and IL-10-polarized macrophages. Macrophages differentiated during 4–5 days with GM-CSF (30 ng/ml) were 
polarized in media containing GM-CSF alone or supplemented with IFN-γ (500 U/ml), IL-4 (10 ng/ml) or 
IL-10 (10 ng/ml) for 2 additional days. Left panels show data from 5 to 9 independent experiments performed 
in duplicate. Horizontal lines connect data from each individual experimental mean fluorescence intensity ratio 
(MFIr) from Media or Mtb-stimulated cells calculated as follows: MFIr = MFI of the indicated marker/MFI 
of the corresponding isotype control. Comparisons between polarizing conditions were done using ANOVA 
followed by Bonferroni posttest and were indicated with #. Alternatively, comparison between stimulated and 
un-stimulated conditions within polarized macrophages were performed with the Wilcoxon signed-rank test, 
and significances were depicted with asterisks. *or #p < 0.05; **or ##p < 0.01; ***or ###p < 0.001. Flow cytometry 
histograms show data from a representative donor under the polarization conditions assayed, depicting for each 
marker the isotype control staining (open gray histogram), expression of the indicated marker on unstimulated 
(open black histograms) or alternatively, on stimulated macrophages (filled gray histograms).
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Figure 5. Study of the expression of PDL-2, CD209, CD14, CD16, CD163 and CD206 on IFN-γ-, IL-4- and IL-
10-polarized macrophages. Macrophages were differentiated as described in Fig. 4. Left panels show data from 
5 to 9 independent experiments performed in duplicate. Horizontal lines connect data from each individual 
experimental mean fluorescence intensity ratio (MFIr) from Media or Mtb-stimulated cells calculated as 
follows: MFIr = MFI of the indicated marker/MFI of the corresponding isotype control. Comparisons between 
polarizing conditions were done using ANOVA followed by Bonferroni posttest and were indicated with #. 
Alternatively, comparison between stimulated and un-stimulated conditions within polarized macrophages 
were performed with the Wilcoxon signed-rank test, and significances were depicted with asterisks. *or 
#p < 0.05; **or ##p < 0.01; ***or ###p < 0.001. Flow cytometry histograms show data from a representative donor 
under the polarization conditions assayed, depicting for each marker the isotype control staining (open gray 
histogram), expression of the indicated marker on unstimulated (open black histograms) or alternatively, on 
stimulated macrophages (filled gray histograms).
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with Mtb or CEF antigens (Fig. 2B–D and Supplementary Fig. 4). These results highlight the relevance of mac-
rophage polarization on T cell cytotoxic responses during tuberculosis infection.
CD8+ T cells can exert cytotoxicity through different mechanisms, including exocytosis of granules, death 
receptors like FAS, and TNF-α37. In this sense, we evinced CD8+ T lymphocyte-macrophage conjugates by both 
flow cytometry and fluorescence microscopy (Fig. 3A–C). In particular, Gzm content in such conjugates was 
greater compared to un-conjugated CD8+ T cells (Fig. 3A), therefore suggesting that conjugated CD8+ T cells 
were effector memory cells, as described previously38. In order to determine whether cytotoxic degranulation was 
involved in CD8+ T cell-induced cytotoxicity, we evaluated granzyme B (Gzm B), perforin (Pfn) and granulysin 
(Gly) transferred from CD8+ T cells to macrophages following co-culture. Thus, to evaluate the Gzm B trans-
fer to macrophages and differentiate it from Gzm B expressed by cytotoxic lymphocytes, we studied the abun-
dance of Gzm in un-conjugated macrophages, inferring that these effector molecules were indeed transferred 
from the cytotoxic lymphocytes. As depicted in Fig. 3A (lower panel), Gzm B content in both un-polarized and 
IFN-γ-polarized macrophages was increased after M. tuberculosis stimulation in comparison with un-stimulated 
cells. This effect was also observed in the transference of Gly, but it could not be detected in Pfn (Fig. 3B). Of note, 
the percentage of Pfn or Gly transfer was much lower than Gzm B transfer in all cases (Fig. 3A,B). Overall, these 
results show that CD8+ T cell cytotoxic degranulation is, at least, a mechanism involved in the cytotoxic process 
performed by antigen-specific lymphocytes.
Effect of M. tuberculosis stimulation on macrophage polarization and PD-L1 expression. As 
described in Fig. 2A, macrophage polarization was induced by activation of monocyte-derived macrophages with 
polarizing cytokines. As expected, we observed that activation of macrophages by IFN-γ significantly increased 
the expression of several molecules involved in antigen presentation and co-stimulation such as HLA-ABC, 
HLA-DR, CD80 and CD86, and also enhanced the expression of the high affinity IgG receptor involved in 
macrophage phagocytosis and activation, CD64 (Fc γ RI)39 (Fig. 4). Moreover, IFN-γ treatment significantly 
augmented PDL-1 (Fig. 4) and PDL-2 (Fig. 5) expression compared to other polarization stimuli. By contrast, 
IL-4 macrophages activation increased the expression of the M2 associated receptor CD209 (DC-SIGN)40 and 
down-modulated CD14, while IL-10 polarization increased surface levels of the M2c markers CD16 (Fc γ RIII) 
and CD163, both associated with tissue inflammation prevention28,41 (Fig. 5). Finally, the expression of the man-
nose receptor CD206 did not change under any polarization conditions (Fig. 5), supporting the notion posed 
previously that CD206 is not a specific marker for M2 polarization28.
Different components of M. tuberculosis can activate pattern recognition receptors (PRR) and therefore they 
can induce or modify macrophage polarization42. Accordingly, we aimed to investigate if gamma-irradiated 
mycobacteria could modify macrophage polarization. We observed that M. tuberculosis stimulation increased 
HLA-ABC expression on un-polarized macrophages, HLA-DR on IFN-γ - and IL-4 - activated macrophages and 
CD86 on IFN-γ - activated macrophages. On the other hand, M. tuberculosis stimulation decreased the surface 
protein levels of CD64 on IFN-γ-activated macrophages, of CD16 both on GM-CSF - and IL-10 - activated mac-
rophages and of PDL-2 on IFN-γ-activated cells (Figs 4 and 5). Notably, among all the markers analyzed, only 
CD80 and PD-L1 were significantly increased by M. tuberculosis stimulation independently of the polarization 
state (Fig. 4). On the contrary, CEF stimulation had no effect on the expression of neither PD-L1 nor PD-L2 
regardless of the activation program (Supplementary Fig. 5). Therefore, M. tuberculosis stimulation exerted a 
significant modulatory effect over M2c macrophage polarization by down-regulating both CD16 and CD163. 
Moreover, it significantly enhanced the expression of CD80 and PD-L1, two molecules involved in the regulation 
of CD8+ T cell activation.
Based on this, since the balance between co-stimulatory and inhibitory signals may determine the magnitude 
of T cell activation29, we decided to compare the effect of macrophage polarization and M. tuberculosis stimula-
tion over PD-L1 and CD80 expression. We therefore observed that the effect of IFN-γ on PD-L1 expression over 
GM-CSF was about four times greater than the increase induced by IFN-γ on CD80 levels, in contrast to other 
polarization conditions, where both receptors increased their expression in similar proportions (Supplementary 
Fig. 6A). Additionally, the combined effect of IFN-γ plus M. tuberculosis stimulation increased two-fold on PD-L1 
expression compared to CD80 over unstimulated conditions -GM-CSF- (Supplementary Fig. 6B).
Based on this, we propose that M1 macrophages and more importantly, the M1 macrophages exposed to M. 
tuberculosis could exert an inhibition on T cell responses through PD-1/PD-L1 interactions.
Effect of PD-L1 blockade on macrophage killing by cytotoxic CD8+ T cells. Taking into account 
that i) PD-Ls were highly expressed in PE cells from TB patients; ii) M1 macrophages were more susceptible to 
cytotoxic killing by CD8+ T cells, and iii) that PD-1 pathway blockade enhanced cytotoxicity and IFN-γ produc-
tion by PEMC from TB patients as observed elsewhere22, we aimed to study the modulatory role of PD-1/PD-Ls 
pathway on CD8+ T cell-driven antigen-specific cytotoxicity. To achieve this, we performed in vitro cytotoxic 
assays in the presence of anti-PD-Ls blocking antibodies, as depicted in Fig. 2A. Thus, we observed that PD-L1 
blocking significantly increased CD8+ T cell cytotoxicity against IFN-γ-activated macrophages loaded both with 
M. tuberculosis (Fig. 6A) or CEF antigens (Fig. 6B). On the contrary, PD-L1 blocking had no effect on in vitro 
cytotoxicity against either un-polarized macrophages, IL-4- or IL-10 treated macrophages (Fig. 6A,B). Moreover, 
PD-L2 blockade did not have any effect on antigen specific cytotoxicity as well (Supplementary Fig. 7, and data 
not shown). Thus, even when IFN-γ -activated macrophages are more susceptible to M. tuberculosis-specific 
CD8+ T cell cytotoxicity, these macrophages can inhibit CD8+ T cell-mediated cytotoxicity by increasing PDL-1 
expression. Finally, we aimed to study the role of PD-1 pathway over CD8+ T cell-driven antigen-specific cytotox-
icity in the context of human tuberculous pleurisy. To that, CD14+ macrophages from TB pleural effusion samples 
were loaded with gamma-irradiated Mtb, extensively washed and co-cultured with autologous CD8+ T cells in 
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Figure 6. Effect of PD-L1 blockade on CD8+ T cell-mediated cytotoxicity. Macrophages were differentiated as 
described above and afterwards were loaded with. (A) Mtb (10 μg/ml) or (B) CEF (1 ng/ml) plus IL-2, and co-
cultured during 18 h with syngeneic CD8+ T cells (previously expanded with the same antigens) at a 2:1 CD8+ T 
cell:Mø ratio, in the presence or absence of anti-PD-L1 blocking antibodies. Horizontal lines connect the results 
from each individual experiment performed in duplicate showing the % of 7-AAD+ macrophages treated with 
PDL-1 blocking antibodies or left untreated. ***p < 0.001 and *p < 0.05 by ANOVA followed by Bonferroni 
post-test. Media values were subtracted and negative values were set to 0. (C) CD14+ and CD8+ cells were 
isolated from tuberculous pleural effusion samples by positive and negative selection, respectively. Afterwards, 
CD14+ macrophages were loaded with gamma-irradiated Mtb (10 μg/ml), extensively washed and co-cultured 
for 18 h with autologous CD8+ T cells in the presence or absence of anti-PDL-1 blocking antibodies. Finally, 
macrophage death was determined by 7-AAD incorporation by flow cytometry. The ratio between 7-AAD+ 
Mtb-treated macrophages and media values were calculated for each donor and horizontal lines connect data 
from each individual. **p < 0.01, Student t Test for paired samples.
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the presence or absence of anti-PD-L1 blocking antibodies. We then observed that PD-L1 blocking enhanced 
Mtb-specific CD8+ T cell mediated killing of CD14+ PE cells (Fig. 6C), therefore highlighting the relevance of 
PD-1 pathway in CD8+ T cell-induced macrophage death during human tuberculosis.
Overall, these results indicate that PD-1/PD-L1 pathway impedes M. tuberculosis-specific cytotoxicity against 
macrophages polarized by IFN-γ to an M1 profile.
Discussion
Control of M. tuberculosis infection depends on both innate and adaptive immune responses. Moreover, effec-
tive killing of infected macrophages is considered a major strategy for bacterial control. In this context, we 
hypothesized that macrophage polarization along with PD-1/PDL-1 pathway can shape the function of cytotoxic 
Mtb-specific CD8 T+ cells. Our results show that PD-1 and PDL-1 molecules were highly expressed at the site 
of infection in TB samples concomitantly with high IFN-γ levels at the site of the tuberculous pleurisy, and their 
expression positively correlated with T-cell cytotoxic functions in human tuberculosis. Moreover, and accord-
ing to our in vitro experiments, we observed that M1 macrophage polarization induced the strongest cytotoxic 
Ag-specific response compared to M2 polarization. Paradoxically, IFN-γ stimulation increased PD-L1 expression 
in macrophages and cytotoxic killing was enhanced when the PD-1 /PDL-1 interaction was abolished. Also, 
blocking PD-L1 pathway only enhanced Ag- specific cytotoxicity in M1 macrophages, therefore unraveling the 
relevance of this interaction in the context of M1 polarization. Finally, the relevance of PD-1 /PD-L1 pathway over 
these processes was unraveled when PDL-1 blocking increased Mtb-specific cytotoxic killing of CD14+ targets 
from human PE samples.
Our observations indicate a relationship between CD8+ T cell cytotoxic potential (measured using CD107a/b 
expression as a surrogate marker for degranulation43) and PD-1 expression on CD8+ T cells and/or PDL-1 expres-
sion on PE CD14+ cells. Previously, we demonstrated that blockage of PD-1/PDL-1 signaling pathway could 
enhance cytotoxic degranulation of CD8+ T cells from TB pleural effusion samples, therefore suggesting a pro-
tective role for PD-1 pathway by limiting tissue damage22. The results presented in this work are in line with the 
above, highlighting the relevance of PD-1/PDL-1 pathway in this process which led us to conclude that PDL-1 
blockade could increase macrophage susceptibility to death by enhancing the cytotoxic potential of CD8+ T cells.
Our results indicate that the activation of macrophages to an M1 profile by IFN-γ increased its suscepti-
bility to lysis by M. tuberculosis- specific CD8+ T lymphocytes compared to non-polarized macrophages 
(GM-CSF-treated) or activated to M2 type profiles (IL-10 or IL-4-treated). Remarkably, the cytotoxic mechanism 
involved, at least, the transfer of lytic molecules to macrophages, as we observed that macrophages expressed Gzm 
B and Gly after co-culture with CD8+ lymphocytes. The fact that those CD8+ T cells with the highest cytotoxic 
molecule expression levels were those associated with polarized macrophages suggests that these CD8+ T cells 
were probably effector cells, as described elsewhere38,44.
This study also demonstrates that Mtb-stimulation did not induce any changes in the overall pheno-
type of IFN-γ or IL-4-polarized macrophages, as shown in Figs 4 and 5. Instead, Mtb stimulation induced a 
down-modulation of CD16 and CD163 expression, two markers for M2c differentiation, on IL-10-treated mac-
rophages. This data acquires relevance in the context of an infection such as tuberculosis, since IL-10 is a cytokine 
dramatically enhanced at the site of infection45 and although we could not detect any changes in vitro, it could 
modify macrophage susceptibility to lysis by CD8+ T cell effectors at the site of infection, as suggested by others14.
Our experimental model included the use of two different antigens. On the one hand, gamma-irradiated 
M. tuberculosis is a particulate antigen which is phagocytized by macrophages42. On the other hand, CEF consist 
of a pool of short peptides from usual viral infections, which do not need to be processed in order to be pre-
sented in the context of HLA-I molecules46. The fact that macrophage polarization by IFN-γ increased CD8+ T 
cells- cytotoxicity to both CEF and Mtb-loaded macrophages in a similar extent, suggests that this effect is not 
related to changes in antigen processing pathways. Alternatively, this increased susceptibility could be related to 
an increased expression of HLA class I and costimulatory molecules, as shown here. In line with this, two previ-
ous reports showed that M2-polarization is related to inhibition of CD8+ T cell cytotoxic responses, and that the 
addition of IFN-γ can revert this inhibition14,47 by increasing CD86 expression14, highlighting the relevance of 
costimulatory molecules in this process.
As demonstrated previously, the balance between the activation and the inhibitory signals defines the ulti-
mate result on T cell activation and function. Our results show that macrophage activation by IFN-γ increased 
PD-L1 expression by 10 fold and that Mtb stimulation further increased it. Intriguingly, the PD-L1 increment 
was particularly high compared to other activating costimulatory molecules like CD80 or CD86. These results 
are in consonance with the increment in PD-L1 expression by CD14+ cells from TB pleural effusions shown in 
Fig. 1. Additionally, our results demonstrate that the PD-L1 blockade increased cytotoxicity to M1-macrophages 
in vitro, but not to M2-macrophages, and that PD-L2 blockade had no effect on cytotoxicity. Therefore, these data 
in addition to the observations showing that PD-L1 blocking enhanced Mtb-specific CD8+ T cell mediated kill-
ing of CD14+ PE cells (Fig. 6C) and the high IFN-γ concentrations in the pleural compartment (Supplementary 
Fig. 1) support the hypothesis indicating that the increment in PD-L1 expression by IFN-γ activation may have 
a protective role by preventing the killing of macrophages. Conversely, PD-L1 induction by Mtb is probably an 
immune evasion mechanism that hinders the killing of infected cells.
Of note, PD-1 expression on CD8+ T cells was highly increased in TB pleural effusions and also it was lim-
ited to a TCM phenotype33 (and Fig. 1), indicating that cytotoxic responses are regulated by this pathway during 
TB pleurisy. Our observations suggest, as detected previously in HIV-TB8 and HIV+ 33 individuals, an arrest of 
exhausted cells on a less differentiated and poor functional phenotype. In this line, Buggert et. al documented a 
CD8+ PD-1+ T-betlow/Eomeshigh TTE population in HIV+ patients with exhausted characteristics and arrested in 
this differentiation state33. Finally, our results are also in line with other authors, who observed a prominent T 
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central memory population and a decrease in terminally-differentiated T cells specific for Ag85A in HIV-negative 
tuberculosis patients, which was reversed following anti-tuberculosis therapy48.
While PD-1 treatment was found to be extremely toxic in animal models of TB infection, its deleterious effects 
were mainly related to its action over CD4+ T cells23,24. Based on our results, it will be of interest to evaluate the 
effect of CD8+ T cell-targeted anti-PD-1 treatments during TB infection focusing on new approaches, such as the 
one described to enhance human Ag-specific cytotoxic-T lymphocytes by performing PD-1 gene knockouts20.
In sum, our results are in line with a model in which, upon recognition of Mtb-infected cells, innate and 
adaptive immune lymphocytes secrete IFN-γ, leading to the activation of macrophages to a M1 profile, therefore 
increasing macrophage susceptibility to CD8+ T cell-mediated cytotoxicity. This effect could be associated with 
the increment in HLA class I and costimulatory molecules expression. In parallel, the same stimulus could lead 
to a higher PD-L1 expression, which combined with the increased PD-1 expression in CD8+ T cells could inhibit 
Mtb-specific CD8+ T cell cytotoxicity. The balance between these stimulatory and inhibitory signals will define 
the fate of the target cell, and finally delineate the resolution of the infection.
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